Latest Breaking News On - Matt greving - Page 1 : comparemela.com

IBio Further Expands Tech Stack with ShieldTx™; Enhances Immuno-Oncology Development Pipeline with Conditionally Activated MUC16xCD3 Bispecific

- ShieldTx potentially increases safety and developability of therapeutic antibodies for difficult targets and modes of action - BRYAN, Texas and SAN DIEGO, Nov. 01, 2023 iBio, Inc. today.

United statesMatt grevingSusan thomasStephen kilmerMartin brennerGlobenewswire incBio incCompany annual report on formWhile the companyDrug discovery platformEpitope steeringMachine learningPlatform technologiesChief executive officerChief scientific officerBiological therapy

iBio to Highlight Technology for Advancing Discovery of Bispecifics at Festival of Biologics

iBio to Highlight Technology for Advancing Discovery of Bispecifics at Festival of Biologics
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesMatt grevingSusan thomasStephen kilmerPlatform companyWhile the companyBio incCompany annual report on formPlatform technologiesVice presidentMachine learningBispecifict cell engager discoveryMammalian displayAvoid when buildingDriven platform companyAnnual report

iBio, Inc (IBIO) Discovers New Panel of CD3 T-Cell Binding Antibodies Using its Patented AI Epitope Steering Platform

iBio, Inc (IBIO) Discovers New Panel of CD3 T-Cell Binding Antibodies Using its Patented AI Epitope Steering Platform
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

San diegoUnited statesMartin brennerMatt grevingBio incMachine learningPlatform technologiesHigh throughput biologyInterim chief executive officerChief scientific officerDesigningt cell engagers with better therapeutic